Cello Health, the healthcare-led advisory group, acquired Innovative Science Solutions, a scientific consulting firm specialising in strategic counsel and regulatory support for the healthcare industry, for $10m. Julia Ralston, CEO of Cello Health US, commented: "We are excited about the acquisition of ISS at this stage in our US evolution. ISS has built a strong reputation for provision of its scientific consulting services. Adding this technical offer will benefit our clients, particularly by tackling their biggest challenges in navigating critical scientific, commercial, and regulatory pathways to successful commercialisation."